This new era of science brings an explosion of new innovation in fields such as cell therapy, gene therapy, antibodies, proteins, and other new drug modalities — as well as a new R&D paradigm.

With the increasing complexity of science, including more data and process orchestration involved in developing new therapeutics, pharmaceutical companies are required to accelerate their progress towards achieving milestones.